Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature
Identifieur interne : 001E75 ( Istex/Corpus ); précédent : 001E74; suivant : 001E76Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature
Auteurs : Yuki Ishikawa ; Naoichiro Yukawa ; Koichiro Ohmura ; Yuji Hosono ; Yoshitaka Imura ; Daisuke Kawabata ; Takaki Nojima ; Takao Fujii ; Takashi Usui ; Tsuneyo MimoriSource :
- Clinical Rheumatology [ 0770-3198 ] ; 2010-05-01.
English descriptors
- KwdEn :
Abstract
Abstract: Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female with rheumatoid arthritis (RA) who had anti-Jo-1 antibodies and interstitial lung disease but no previous history of PM/DM and who developed PM soon after the initiation of etanercept (ETN) therapy for RA. The patient recovered upon withdrawal from ETN and corticosteroid (CS) therapies. Only four reports of PM/DM associated with anti-TNF therapy for RA could be found in the literature. The patients described in three of the four reports were positive for anti-Jo-1 antibodies before the initiation of anti-TNF therapy, and in all the cases, recovery occurred after the cessation of anti-TNF-agent administration and CS therapy. These results suggest a relationship between the onset of PM/DM with anti-Jo-1 antibody and anti-TNF therapy for RA.
Url:
DOI: 10.1007/s10067-009-1370-1
Links to Exploration step
ISTEX:AD872DD7FBF2A41C1D942718F027AAB30ACB88E8Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title><author><name sortKey="Ishikawa, Yuki" sort="Ishikawa, Yuki" uniqKey="Ishikawa Y" first="Yuki" last="Ishikawa">Yuki Ishikawa</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Yukawa, Naoichiro" sort="Yukawa, Naoichiro" uniqKey="Yukawa N" first="Naoichiro" last="Yukawa">Naoichiro Yukawa</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: naoichiy@kuhp.kyoto-u.ac.jp</mods:affiliation></affiliation></author><author><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Hosono, Yuji" sort="Hosono, Yuji" uniqKey="Hosono Y" first="Yuji" last="Hosono">Yuji Hosono</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Imura, Yoshitaka" sort="Imura, Yoshitaka" uniqKey="Imura Y" first="Yoshitaka" last="Imura">Yoshitaka Imura</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kawabata, Daisuke" sort="Kawabata, Daisuke" uniqKey="Kawabata D" first="Daisuke" last="Kawabata">Daisuke Kawabata</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nojima, Takaki" sort="Nojima, Takaki" uniqKey="Nojima T" first="Takaki" last="Nojima">Takaki Nojima</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Usui, Takashi" sort="Usui, Takashi" uniqKey="Usui T" first="Takashi" last="Usui">Takashi Usui</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AD872DD7FBF2A41C1D942718F027AAB30ACB88E8</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1007/s10067-009-1370-1</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-LZDZ0SBZ-Q/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001E75</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E75</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title><author><name sortKey="Ishikawa, Yuki" sort="Ishikawa, Yuki" uniqKey="Ishikawa Y" first="Yuki" last="Ishikawa">Yuki Ishikawa</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Yukawa, Naoichiro" sort="Yukawa, Naoichiro" uniqKey="Yukawa N" first="Naoichiro" last="Yukawa">Naoichiro Yukawa</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: naoichiy@kuhp.kyoto-u.ac.jp</mods:affiliation></affiliation></author><author><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Hosono, Yuji" sort="Hosono, Yuji" uniqKey="Hosono Y" first="Yuji" last="Hosono">Yuji Hosono</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Imura, Yoshitaka" sort="Imura, Yoshitaka" uniqKey="Imura Y" first="Yoshitaka" last="Imura">Yoshitaka Imura</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kawabata, Daisuke" sort="Kawabata, Daisuke" uniqKey="Kawabata D" first="Daisuke" last="Kawabata">Daisuke Kawabata</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nojima, Takaki" sort="Nojima, Takaki" uniqKey="Nojima T" first="Takaki" last="Nojima">Takaki Nojima</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Usui, Takashi" sort="Usui, Takashi" uniqKey="Usui T" first="Takashi" last="Usui">Takashi Usui</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author><author><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Rheumatology</title><title level="j" type="sub">Journal of the International League of Associations for Rheumatology</title><title level="j" type="abbrev">Clin Rheumatol</title><idno type="ISSN">0770-3198</idno><idno type="eISSN">1434-9949</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>London</pubPlace><date type="published" when="2010-05-01">2010-05-01</date><biblScope unit="volume">29</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="563">563</biblScope><biblScope unit="page" to="566">566</biblScope></imprint><idno type="ISSN">0770-3198</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0770-3198</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Jo-1 antibody</term><term>Anti-TNF therapy</term><term>Antisynthetase antibodies</term><term>Dermatomyositis</term><term>Polymyositis</term><term>Rheumatoid arthritis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female with rheumatoid arthritis (RA) who had anti-Jo-1 antibodies and interstitial lung disease but no previous history of PM/DM and who developed PM soon after the initiation of etanercept (ETN) therapy for RA. The patient recovered upon withdrawal from ETN and corticosteroid (CS) therapies. Only four reports of PM/DM associated with anti-TNF therapy for RA could be found in the literature. The patients described in three of the four reports were positive for anti-Jo-1 antibodies before the initiation of anti-TNF therapy, and in all the cases, recovery occurred after the cessation of anti-TNF-agent administration and CS therapy. These results suggest a relationship between the onset of PM/DM with anti-Jo-1 antibody and anti-TNF therapy for RA.</div></front></TEI><istex><corpusName>springer-journals</corpusName><author><json:item><name>Yuki Ishikawa</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Naoichiro Yukawa</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string><json:string>E-mail: naoichiy@kuhp.kyoto-u.ac.jp</json:string></affiliations></json:item><json:item><name>Koichiro Ohmura</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Yuji Hosono</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Yoshitaka Imura</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Daisuke Kawabata</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Takaki Nojima</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Takao Fujii</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Takashi Usui</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item><json:item><name>Tsuneyo Mimori</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</json:string><json:string>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Anti-Jo-1 antibody</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Antisynthetase antibodies</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Anti-TNF therapy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Dermatomyositis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Polymyositis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Rheumatoid arthritis</value></json:item></subject><articleId><json:string>1370</json:string><json:string>s10067-009-1370-1</json:string></articleId><arkIstex>ark:/67375/VQC-LZDZ0SBZ-Q</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>Report</json:string></originalGenre><abstract>Abstract: Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female with rheumatoid arthritis (RA) who had anti-Jo-1 antibodies and interstitial lung disease but no previous history of PM/DM and who developed PM soon after the initiation of etanercept (ETN) therapy for RA. The patient recovered upon withdrawal from ETN and corticosteroid (CS) therapies. Only four reports of PM/DM associated with anti-TNF therapy for RA could be found in the literature. The patients described in three of the four reports were positive for anti-Jo-1 antibodies before the initiation of anti-TNF therapy, and in all the cases, recovery occurred after the cessation of anti-TNF-agent administration and CS therapy. These results suggest a relationship between the onset of PM/DM with anti-Jo-1 antibody and anti-TNF therapy for RA.</abstract><qualityIndicators><refBibsNative>false</refBibsNative><abstractWordCount>153</abstractWordCount><abstractCharCount>1055</abstractCharCount><keywordCount>6</keywordCount><score>5.936</score><pdfWordCount>2100</pdfWordCount><pdfCharCount>14530</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>595.276 x 790.866 pts</pdfPageSize></qualityIndicators><title>Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title><genre><json:string>research-article</json:string></genre><host><title>Clinical Rheumatology</title><language><json:string>unknown</json:string></language><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><issn><json:string>0770-3198</json:string></issn><eissn><json:string>1434-9949</json:string></eissn><journalId><json:string>10067</json:string></journalId><volume>29</volume><issue>5</issue><pages><first>563</first><last>566</last></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Rheumatology</value></json:item></subject></host><ark><json:string>ark:/67375/VQC-LZDZ0SBZ-Q</json:string></ark><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1007/s10067-009-1370-1</json:string></doi><id>AD872DD7FBF2A41C1D942718F027AAB30ACB88E8</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-LZDZ0SBZ-Q/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-LZDZ0SBZ-Q/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-LZDZ0SBZ-Q/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">Springer-Verlag</publisher><pubPlace>London</pubPlace><availability><licence><p>Clinical Rheumatology, 2010</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p></availability><date>2009-11-13</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Case Report</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title><author xml:id="author-0000"><persName><forename type="first">Yuki</forename><surname>Ishikawa</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0001" corresp="yes"><persName><forename type="first">Naoichiro</forename><surname>Yukawa</surname></persName><email>naoichiy@kuhp.kyoto-u.ac.jp</email><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0002"><persName><forename type="first">Koichiro</forename><surname>Ohmura</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0003"><persName><forename type="first">Yuji</forename><surname>Hosono</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0004"><persName><forename type="first">Yoshitaka</forename><surname>Imura</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0005"><persName><forename type="first">Daisuke</forename><surname>Kawabata</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0006"><persName><forename type="first">Takaki</forename><surname>Nojima</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0007"><persName><forename type="first">Takao</forename><surname>Fujii</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0008"><persName><forename type="first">Takashi</forename><surname>Usui</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><author xml:id="author-0009"><persName><forename type="first">Tsuneyo</forename><surname>Mimori</surname></persName><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation></author><idno type="istex">AD872DD7FBF2A41C1D942718F027AAB30ACB88E8</idno><idno type="ark">ark:/67375/VQC-LZDZ0SBZ-Q</idno><idno type="DOI">10.1007/s10067-009-1370-1</idno><idno type="article-id">1370</idno><idno type="article-id">s10067-009-1370-1</idno></analytic><monogr><title level="j">Clinical Rheumatology</title><title level="j" type="sub">Journal of the International League of Associations for Rheumatology</title><title level="j" type="abbrev">Clin Rheumatol</title><idno type="pISSN">0770-3198</idno><idno type="eISSN">1434-9949</idno><idno type="journal-ID">true</idno><idno type="issue-article-count">21</idno><idno type="volume-issue-count">12</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>London</pubPlace><date type="published" when="2010-05-01"></date><biblScope unit="volume">29</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="563">563</biblScope><biblScope unit="page" to="566">566</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009-11-13</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Abstract: Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female with rheumatoid arthritis (RA) who had anti-Jo-1 antibodies and interstitial lung disease but no previous history of PM/DM and who developed PM soon after the initiation of etanercept (ETN) therapy for RA. The patient recovered upon withdrawal from ETN and corticosteroid (CS) therapies. Only four reports of PM/DM associated with anti-TNF therapy for RA could be found in the literature. The patients described in three of the four reports were positive for anti-Jo-1 antibodies before the initiation of anti-TNF therapy, and in all the cases, recovery occurred after the cessation of anti-TNF-agent administration and CS therapy. These results suggest a relationship between the onset of PM/DM with anti-Jo-1 antibody and anti-TNF therapy for RA.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Anti-Jo-1 antibody</term></item><item><term>Antisynthetase antibodies</term></item><item><term>Anti-TNF therapy</term></item><item><term>Dermatomyositis</term></item><item><term>Polymyositis</term></item><item><term>Rheumatoid arthritis</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Medicine & Public Health</head><item><term>Rheumatology</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-11-13">Created</change><change when="2010-05-01">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-LZDZ0SBZ-Q/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer-Verlag</PublisherName><PublisherLocation>London</PublisherLocation></PublisherInfo><Journal OutputMedium="All"><JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"><JournalID>10067</JournalID><JournalPrintISSN>0770-3198</JournalPrintISSN><JournalElectronicISSN>1434-9949</JournalElectronicISSN><JournalTitle>Clinical Rheumatology</JournalTitle><JournalSubTitle>Journal of the International League of Associations for Rheumatology</JournalSubTitle><JournalAbbreviatedTitle>Clin Rheumatol</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Type="Secondary">Rheumatology </JournalSubject></JournalSubjectGroup></JournalInfo><Volume OutputMedium="All"><VolumeInfo TocLevels="0" VolumeType="Regular"><VolumeIDStart>29</VolumeIDStart><VolumeIDEnd>29</VolumeIDEnd><VolumeIssueCount>12</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular" OutputMedium="All"><IssueInfo IssueType="Regular" TocLevels="0"><IssueIDStart>5</IssueIDStart><IssueIDEnd>5</IssueIDEnd><IssueArticleCount>21</IssueArticleCount><IssueHistory><OnlineDate><Year>2010</Year><Month>3</Month><Day>23</Day></OnlineDate><PrintDate><Year>2010</Year><Month>3</Month><Day>22</Day></PrintDate><CoverDate><Year>2010</Year><Month>5</Month></CoverDate><PricelistYear>2010</PricelistYear></IssueHistory><IssueCopyright><CopyrightHolderName>Clinical Rheumatology</CopyrightHolderName><CopyrightYear>2010</CopyrightYear></IssueCopyright></IssueInfo><Article ID="s10067-009-1370-1" OutputMedium="All"><ArticleInfo ArticleType="Report" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"><ArticleID>1370</ArticleID><ArticleDOI>10.1007/s10067-009-1370-1</ArticleDOI><ArticleSequenceNumber>19</ArticleSequenceNumber><ArticleTitle Language="En">Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</ArticleTitle><ArticleCategory>Case Report</ArticleCategory><ArticleFirstPage>563</ArticleFirstPage><ArticleLastPage>566</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2009</Year><Month>12</Month><Day>24</Day></RegistrationDate><Received><Year>2009</Year><Month>11</Month><Day>13</Day></Received><Accepted><Year>2009</Year><Month>12</Month><Day>23</Day></Accepted><OnlineDate><Year>2010</Year><Month>2</Month><Day>9</Day></OnlineDate></ArticleHistory><ArticleCopyright><CopyrightHolderName>Clinical Rheumatology</CopyrightHolderName><CopyrightYear>2010</CopyrightYear></ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ArticleGrants></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Yuki</GivenName><FamilyName>Ishikawa</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2" CorrespondingAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Naoichiro</GivenName><FamilyName>Yukawa</FamilyName></AuthorName><Contact><Phone>+81-75-7514380</Phone><Fax>+81-75-7514338</Fax><Email>naoichiy@kuhp.kyoto-u.ac.jp</Email></Contact></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Koichiro</GivenName><FamilyName>Ohmura</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Yuji</GivenName><FamilyName>Hosono</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Yoshitaka</GivenName><FamilyName>Imura</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Daisuke</GivenName><FamilyName>Kawabata</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Takaki</GivenName><FamilyName>Nojima</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Takao</GivenName><FamilyName>Fujii</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Takashi</GivenName><FamilyName>Usui</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1 Aff2"><AuthorName DisplayOrder="Western"><GivenName>Tsuneyo</GivenName><FamilyName>Mimori</FamilyName></AuthorName></Author><Affiliation ID="Aff1"><OrgDivision>Department of Rheumatology and Clinical Immunology</OrgDivision><OrgName>Kyoto University Hospital</OrgName><OrgAddress><City>Kyoto City</City><State>Kyoto</State><Country Code="JP">Japan</Country></OrgAddress></Affiliation><Affiliation ID="Aff2"><OrgDivision>Graduate School of Medicine</OrgDivision><OrgName>Kyoto University</OrgName><OrgAddress><City>Kyoto City</City><State>Kyoto</State><Country Code="JP">Japan</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En" OutputMedium="All"><Heading>Abstract</Heading><Para>Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female with rheumatoid arthritis (RA) who had anti-Jo-1 antibodies and interstitial lung disease but no previous history of PM/DM and who developed PM soon after the initiation of etanercept (ETN) therapy for RA. The patient recovered upon withdrawal from ETN and corticosteroid (CS) therapies. Only four reports of PM/DM associated with anti-TNF therapy for RA could be found in the literature. The patients described in three of the four reports were positive for anti-Jo-1 antibodies before the initiation of anti-TNF therapy, and in all the cases, recovery occurred after the cessation of anti-TNF-agent administration and CS therapy. These results suggest a relationship between the onset of PM/DM with anti-Jo-1 antibody and anti-TNF therapy for RA.</Para></Abstract><KeywordGroup Language="En" OutputMedium="All"><Heading>Keywords</Heading><Keyword>Anti-Jo-1 antibody</Keyword><Keyword>Antisynthetase antibodies</Keyword><Keyword>Anti-TNF therapy</Keyword><Keyword>Dermatomyositis</Keyword><Keyword>Polymyositis</Keyword><Keyword>Rheumatoid arthritis</Keyword></KeywordGroup></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature</title></titleInfo><name type="personal"><namePart type="given">Yuki</namePart><namePart type="family">Ishikawa</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal" displayLabel="corresp"><namePart type="given">Naoichiro</namePart><namePart type="family">Yukawa</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><affiliation>E-mail: naoichiy@kuhp.kyoto-u.ac.jp</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Koichiro</namePart><namePart type="family">Ohmura</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yuji</namePart><namePart type="family">Hosono</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yoshitaka</namePart><namePart type="family">Imura</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Daisuke</namePart><namePart type="family">Kawabata</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Takaki</namePart><namePart type="family">Nojima</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Takao</namePart><namePart type="family">Fujii</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Takashi</namePart><namePart type="family">Usui</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Tsuneyo</namePart><namePart type="family">Mimori</namePart><affiliation>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto City, Kyoto, Japan</affiliation><affiliation>Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Report" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>Springer-Verlag</publisher><place><placeTerm type="text">London</placeTerm></place><dateCreated encoding="w3cdtf">2009-11-13</dateCreated><dateIssued encoding="w3cdtf">2010-05-01</dateIssued><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract lang="en">Abstract: Antitumor necrosis factor (TNF) therapy has been associated with adverse immunologic events including systemic lupus erythematosus. However, the development of polymyositis (PM)/dermatomyositis (DM) associated with anti-TNF therapy is extremely rare. We experienced a case of a 48-year-old female with rheumatoid arthritis (RA) who had anti-Jo-1 antibodies and interstitial lung disease but no previous history of PM/DM and who developed PM soon after the initiation of etanercept (ETN) therapy for RA. The patient recovered upon withdrawal from ETN and corticosteroid (CS) therapies. Only four reports of PM/DM associated with anti-TNF therapy for RA could be found in the literature. The patients described in three of the four reports were positive for anti-Jo-1 antibodies before the initiation of anti-TNF therapy, and in all the cases, recovery occurred after the cessation of anti-TNF-agent administration and CS therapy. These results suggest a relationship between the onset of PM/DM with anti-Jo-1 antibody and anti-TNF therapy for RA.</abstract><note>Case Report</note><subject lang="en"><genre>Keywords</genre><topic>Anti-Jo-1 antibody</topic><topic>Antisynthetase antibodies</topic><topic>Anti-TNF therapy</topic><topic>Dermatomyositis</topic><topic>Polymyositis</topic><topic>Rheumatoid arthritis</topic></subject><relatedItem type="host"><titleInfo><title>Clinical Rheumatology</title><subTitle>Journal of the International League of Associations for Rheumatology</subTitle></titleInfo><titleInfo type="abbreviated"><title>Clin Rheumatol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>Springer</publisher><dateIssued encoding="w3cdtf">2010-03-23</dateIssued><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><subject><genre>Medicine & Public Health</genre><topic>Rheumatology</topic></subject><identifier type="ISSN">0770-3198</identifier><identifier type="eISSN">1434-9949</identifier><identifier type="JournalID">10067</identifier><identifier type="IssueArticleCount">21</identifier><identifier type="VolumeIssueCount">12</identifier><part><date>2010</date><detail type="volume"><number>29</number><caption>vol.</caption></detail><detail type="issue"><number>5</number><caption>no.</caption></detail><extent unit="pages"><start>563</start><end>566</end></extent></part><recordInfo><recordOrigin>Clinical Rheumatology, 2010</recordOrigin></recordInfo></relatedItem><identifier type="istex">AD872DD7FBF2A41C1D942718F027AAB30ACB88E8</identifier><identifier type="ark">ark:/67375/VQC-LZDZ0SBZ-Q</identifier><identifier type="DOI">10.1007/s10067-009-1370-1</identifier><identifier type="ArticleID">1370</identifier><identifier type="ArticleID">s10067-009-1370-1</identifier><accessCondition type="use and reproduction" contentType="copyright">Clinical Rheumatology, 2010</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource><recordOrigin>Clinical Rheumatology, 2010</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-LZDZ0SBZ-Q/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001E75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:AD872DD7FBF2A41C1D942718F027AAB30ACB88E8
|texte= Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature
}}
| This area was generated with Dilib version V0.6.33. |  |